Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.76B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$776M |
| 3 |
Alibaba
BABA
|
+$405M |
| 4 |
Stellantis
STLA
|
+$331M |
| 5 |
First Horizon
FHN
|
+$314M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.92B |
| 2 |
Microsoft
MSFT
|
+$1.8B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.25B |
| 4 |
Amazon
AMZN
|
+$1.1B |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$982M |
Sector Composition
| 1 | Technology | 22.73% |
| 2 | Financials | 14.83% |
| 3 | Healthcare | 10.55% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Communication Services | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
CarParts.com
PRTS
$41.9M
| $1.34M | ﹤0.01% |
+199,962
| New | +$1.34M |
|
2027
TG Therapeutics
TGTX
$5.09B
| $1.33M | ﹤0.01% |
140,291
-78,104
| -36% | -$743K |
|
|
AAN
2028
DELISTED
The Aaron's Company, Inc.
AAN
| $1.33M | ﹤0.01% |
+66,353
| New | +$1.33M |
|
2029
Northwest Natural Holdings
NWN
$1.73B
| $1.33M | ﹤0.01% |
25,697
-14,189
| -36% | -$734K |
|
|
LEV
2030
DELISTED
The Lion Electric Company
LEV
| $1.33M | ﹤0.01% |
+158,100
| New | +$1.33M |
|
|
OCA
2031
DELISTED
Omnichannel Acquisition Corp.
OCA
| $1.33M | ﹤0.01% |
+133,108
| New | +$1.33M |
|
2032
LeMaitre Vascular
LMAT
$2.08B
| $1.32M | ﹤0.01% |
28,464
+3,733
| +15% | +$174K |
|
2033
Harmony Biosciences
HRMY
$1.85B
| $1.32M | ﹤0.01% |
+27,179
| New | +$1.32M |
|
2034
Kilroy Realty
KRC
$5.17B
| $1.32M | ﹤0.01% |
17,257
-26,314
| -60% | -$2.01M |
|
2035
Palomar
PLMR
$3.08B
| $1.32M | ﹤0.01% |
20,639
-11,412
| -36% | -$730K |
|
2036
Aura Biosciences
AURA
$379M
| $1.31M | ﹤0.01% |
+59,697
| New | +$1.31M |
|
|
NVEE
2037
DELISTED
NV5 Global
NVEE
| $1.31M | ﹤0.01% |
39,444
-28,972
| -42% | -$965K |
|
2038
Navient
NAVI
$1.3B
| $1.31M | ﹤0.01% |
76,965
-160,469
| -68% | -$2.74M |
|
2039
Cohen & Steers
CNS
$3.54B
| $1.31M | ﹤0.01% |
15,218
-25,159
| -62% | -$2.16M |
|
2040
Harmonic Inc
HLIT
$1.14B
| $1.31M | ﹤0.01% |
140,759
-52,491
| -27% | -$487K |
|
|
SUM
2041
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $1.31M | ﹤0.01% |
42,766
-132,275
| -76% | -$4.04M |
|
|
TGI
2042
DELISTED
Triumph Group
TGI
| $1.31M | ﹤0.01% |
51,615
-31,665
| -38% | -$801K |
|
|
DHR.PRB
2043
DELISTED
Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B
DHR.PRB
| $1.3M | ﹤0.01% |
+826
| New | +$1.3M |
|
2044
Community Health Systems
CYH
$412M
| $1.29M | ﹤0.01% |
108,880
-58,004
| -35% | -$689K |
|
|
ICPT
2045
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.29M | ﹤0.01% |
79,384
+37,305
| +89% | +$607K |
|
|
ZWRK
2046
DELISTED
Z-Work Acquisition Corp. Class A Common Stock
ZWRK
| $1.29M | ﹤0.01% |
+132,000
| New | +$1.29M |
|
2047
NeoGenomics
NEO
$1.05B
| $1.29M | ﹤0.01% |
106,212
-50,288
| -32% | -$611K |
|
2048
Syndax Pharmaceuticals
SNDX
$1.27B
| $1.29M | ﹤0.01% |
74,234
-701,242
| -90% | -$12.2M |
|
|
VGR
2049
DELISTED
Vector Group Ltd.
VGR
| $1.29M | ﹤0.01% |
106,787
-79,650
| -43% | -$959K |
|
2050
Concentrix
CNXC
$3.5B
| $1.28M | ﹤0.01% |
+7,671
| New | +$1.28M |
|